First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210029, China
NCT Number: NCT06322914
The investigators conducted a retrospective, single-center observational registry upon which one novel scoring system was formed and evaluated for their accuracy in predicting technical success. The investigators reviewed the clinical and angiographic records of 432 patients with 459 CTO lesions who underwent percutaneous recanalization attempts recruited between January 2012 and November 2023. The investigators aims to develop and validate a novel scoring system for predicting CTO-PCI success.
Looking for future studies?
Notify MeAll sexes
Observational
Nanjing, Jiangsu, 210029, China
Chronic total occlusions (CTO) accounting for about 15-20% of coronary artery lesions can be challenging and only 10-15% of patients undergo successful percutaneous coronary intervention (PCI) .Thanks to the technological and device advances, the marked improvement of PCI success rates could be seen. However, in contrast to non-CTO lesions, these procedures are accompanied by longer procedure time, contrast and radiation burden, and higher complication rates. The possibility to predict which CTOs are more likely to be treated successfully is still of utmost importance for patient selection. Several scores have been proposed to predict the procedural success rate, such as J-CTO, CL-Score, Progress-Score et al , J-CTO is widely accepted. But Karatasakis et al.showed that these scores performed moderately in predicting technical outcome, while ignoring many factors such as stumpless lesion which may exert an influence on the procedural success. The investigators aims to develop and validate a novel scoring system for predicting CTO-PCI success.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: immediately after PCI
Technical success of CTO PCI was defined as successful revascularization with <30% residual diameter stenosis and restoration of antegrade TIMI flow grade 3
of <30% residual diameter stenosis within the treated segment and restoration of antegrade TIMI flow grade 3.
The First Affiliated Hospital with Nanjing Medical University
Other
A Novel Scoring System for Predicting the Success of Percutaneous Coronary Interventions in Patients With Chronic Total Occlusion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07473596
Arterial Occlusive Diseases, Arteriosclerosis
Helsinki, Uusimaa, Finland
View Trial DetailsNCT06728384
Absolute Flow Measurement, Chronic Total Occlusion (CTO)
Nijmegen, Netherlands
View Trial DetailsNCT06030271
Arterial Occlusive Diseases, Arteriosclerosis
Tbilisi, Georgia
View Trial DetailsNCT01435031
Arterial Occlusive Diseases, Arteriosclerosis
Santa Clara, California, United States
View Trial Details